Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Zika Virus Outbreak on Curaçao and Bonaire, a Report Based on Laboratory Diagnostics Data.

Lim SM, Wever R, Pas SD, Bonofacio G, Koopmans MPG, Martina BEE.

Front Public Health. 2019 Nov 12;7:333. doi: 10.3389/fpubh.2019.00333. eCollection 2019.

2.

Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection.

Cabral-Miranda G, Lim SM, Mohsen MO, Pobelov IV, Roesti ES, Heath MD, Skinner MA, Kramer MF, Martina BEE, Bachmann MF.

Vaccines (Basel). 2019 Jul 23;7(3). pii: E72. doi: 10.3390/vaccines7030072.

3.

Characterization of antibody response in patients with acute and chronic chikungunya virus disease.

Anfasa F, Lim SM, Fekken S, Wever R, Osterhaus ADME, Martina BEE.

J Clin Virol. 2019 Aug;117:68-72. doi: 10.1016/j.jcv.2019.06.001. Epub 2019 Jun 10.

PMID:
31229935
4.

Zika Virus Infection Induces Elevation of Tissue Factor Production and Apoptosis on Human Umbilical Vein Endothelial Cells.

Anfasa F, Goeijenbier M, Widagdo W, Siegers JY, Mumtaz N, Okba N, van Riel D, Rockx B, Koopmans MPG, Meijers JCM, Martina BEE.

Front Microbiol. 2019 Apr 24;10:817. doi: 10.3389/fmicb.2019.00817. eCollection 2019.

5.

The possible role of cross-reactive dengue virus antibodies in Zika virus pathogenesis.

Langerak T, Mumtaz N, Tolk VI, van Gorp ECM, Martina BE, Rockx B, Koopmans MPG.

PLoS Pathog. 2019 Apr 18;15(4):e1007640. doi: 10.1371/journal.ppat.1007640. eCollection 2019 Apr. Review.

6.

Combination drug treatment prolongs survival of experimentally infected mice with silver-haired bat rabies virus.

Martina BEE, Smreczak M, Orlowska A, Marzec A, Trebas P, Roose JM, Zmudzinski J, Gerhauser I, Wohlsein P, Baumgärtner W, Osterhaus ADME, Koraka P.

Vaccine. 2019 Aug 2;37(33):4736-4742. doi: 10.1016/j.vaccine.2018.05.065. Epub 2018 May 26.

7.

Inhibition of caspase-1 prolongs survival of mice infected with rabies virus.

Koraka P, Martina BEE, Smreczak M, Orlowska A, Marzec A, Trebas P, Roose JM, Begeman L, Gerhauser I, Wohlsein P, Baumgärtner W, Zmudzinski J, D M E Osterhaus A.

Vaccine. 2019 Aug 2;37(33):4681-4685. doi: 10.1016/j.vaccine.2018.04.002. Epub 2018 Apr 10.

8.

Analysis of Mouse Brain Transcriptome After Experimental Duvenhage Virus Infection Shows Activation of Innate Immune Response and Pyroptotic Cell Death Pathway.

Koraka P, Martina BEE, van den Ham HJ, Zaaraoui-Boutahar F, van IJcken W, Roose J, van Amerongen G, Andeweg A, Osterhaus ADME.

Front Microbiol. 2018 Mar 20;9:397. doi: 10.3389/fmicb.2018.00397. eCollection 2018.

9.

Transcriptomic Analyses Reveal Differential Gene Expression of Immune and Cell Death Pathways in the Brains of Mice Infected with West Nile Virus and Chikungunya Virus.

Lim SM, van den Ham HJ, Oduber M, Martina E, Zaaraoui-Boutahar F, Roose JM, van IJcken WFJ, Osterhaus ADME, Andeweg AC, Koraka P, Martina BEE.

Front Microbiol. 2017 Aug 17;8:1556. doi: 10.3389/fmicb.2017.01556. eCollection 2017.

10.

Phenotypic Differences between Asian and African Lineage Zika Viruses in Human Neural Progenitor Cells.

Anfasa F, Siegers JY, van der Kroeg M, Mumtaz N, Stalin Raj V, de Vrij FMS, Widagdo W, Gabriel G, Salinas S, Simonin Y, Reusken C, Kushner SA, Koopmans MPG, Haagmans B, Martina BEE, van Riel D.

mSphere. 2017 Jul 26;2(4). pii: e00292-17. doi: 10.1128/mSphere.00292-17. eCollection 2017 Jul-Aug.

11.

Serologic evidence of West Nile virus and Usutu virus infections in Eurasian coots in the Netherlands.

Lim SM, Geervliet M, Verhagen JH, Müskens GJDM, Majoor FA, Osterhaus ADME, Martina BEE.

Zoonoses Public Health. 2018 Feb;65(1):96-102. doi: 10.1111/zph.12375. Epub 2017 Jul 7.

PMID:
28688117
12.

Human to human transmission of arthropod-borne pathogens.

Martina BE, Barzon L, Pijlman GP, de la Fuente J, Rizzoli A, Wammes LJ, Takken W, van Rij RP, Papa A.

Curr Opin Virol. 2017 Feb;22:13-21. doi: 10.1016/j.coviro.2016.11.005. Epub 2016 Dec 2. Review.

PMID:
27915056
13.

Hyperferritinemia is a potential marker of chronic chikungunya: A retrospective study on the Island of Curaçao during the 2014-2015 outbreak.

Anfasa F, Provacia L, GeurtsvanKessel C, Wever R, Gerstenbluth I, Osterhaus AD, Martina BE.

J Clin Virol. 2017 Jan;86:31-38. doi: 10.1016/j.jcv.2016.11.003. Epub 2016 Nov 18.

14.

Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens.

Volz A, Lim S, Kaserer M, Lülf A, Marr L, Jany S, Deeg CA, Pijlman GP, Koraka P, Osterhaus AD, Martina BE, Sutter G.

Vaccine. 2016 Apr 7;34(16):1915-26. doi: 10.1016/j.vaccine.2016.02.042. Epub 2016 Mar 2.

PMID:
26939903
15.

In Vitro and in Vivo Evaluation of Mutations in the NS Region of Lineage 2 West Nile Virus Associated with Neuroinvasiveness in a Mammalian Model.

Szentpáli-Gavallér K, Lim SM, Dencső L, Bányai K, Koraka P, Osterhaus AD, Martina BE, Bakonyi T, Bálint Á.

Viruses. 2016 Feb 19;8(2). pii: E49. doi: 10.3390/v8020049.

16.

Neurotropic virus infections as the cause of immediate and delayed neuropathology.

Ludlow M, Kortekaas J, Herden C, Hoffmann B, Tappe D, Trebst C, Griffin DE, Brindle HE, Solomon T, Brown AS, van Riel D, Wolthers KC, Pajkrt D, Wohlsein P, Martina BEE, Baumgärtner W, Verjans GM, Osterhaus ADME.

Acta Neuropathol. 2016 Feb;131(2):159-184. doi: 10.1007/s00401-015-1511-3. Epub 2015 Dec 10. Review.

17.

Emerging Viruses in the Republic of Suriname: Retrospective and Prospective Study into Chikungunya Circulation and Suspicion of Human Hantavirus Infections, 2008-2012 and 2014.

Goeijenbier M, Aron G, Anfasa F, Lundkvist Å, Verner-Carlsson J, Reusken CB, Martina BE, van Gorp EC, Resida L.

Vector Borne Zoonotic Dis. 2015 Oct;15(10):611-8. doi: 10.1089/vbz.2015.1798. Epub 2015 Sep 22.

PMID:
26393384
18.

Comparative Usutu and West Nile virus transmission potential by local Culex pipiens mosquitoes in north-western Europe.

Fros JJ, Miesen P, Vogels CB, Gaibani P, Sambri V, Martina BE, Koenraadt CJ, van Rij RP, Vlak JM, Takken W, Pijlman GP.

One Health. 2015 Sep 6;1:31-36. doi: 10.1016/j.onehlt.2015.08.002. eCollection 2015 Dec.

19.

Susceptibility of Carrion Crows to Experimental Infection with Lineage 1 and 2 West Nile Viruses.

Lim SM, Brault AC, van Amerongen G, Bosco-Lauth AM, Romo H, Sewbalaksing VD, Bowen RA, Osterhaus AD, Koraka P, Martina BE.

Emerg Infect Dis. 2015 Aug;21(8):1357-65. doi: 10.3201/2108.140714.

20.

Markers of endothelial cell activation and immune activation are increased in patients with severe leptospirosis and associated with disease severity.

Goeijenbier M, Gasem MH, Meijers JC, Hartskeerl RA, Ahmed A, Goris MG, Isbandrio B, Schuller SS, Osterhaus AD, Martina BE, van Gorp EC, Nally JE, Wagenaar JF.

J Infect. 2015 Oct;71(4):437-46. doi: 10.1016/j.jinf.2015.05.016. Epub 2015 Jun 3.

PMID:
26048204
21.

Effect of Puumala hantavirus infection on human umbilical vein endothelial cell hemostatic function: platelet interactions, increased tissue factor expression and fibrinolysis regulator release.

Goeijenbier M, Meijers JC, Anfasa F, Roose JM, van de Weg CA, Bakhtiari K, Henttonen H, Vaheri A, Osterhaus AD, van Gorp EC, Martina BE.

Front Microbiol. 2015 Mar 24;6:220. doi: 10.3389/fmicb.2015.00220. eCollection 2015.

22.

Time since onset of disease and individual clinical markers associate with transcriptional changes in uncomplicated dengue.

van de Weg CA, van den Ham HJ, Bijl MA, Anfasa F, Zaaraoui-Boutahar F, Dewi BE, Nainggolan L, van IJcken WF, Osterhaus AD, Martina BE, van Gorp EC, Andeweg AC.

PLoS Negl Trop Dis. 2015 Mar 13;9(3):e0003522. doi: 10.1371/journal.pntd.0003522. eCollection 2015 Mar.

23.

Dengue pathogenesis: a disease driven by the host response.

Martina BE.

Sci Prog. 2014;97(Pt 3):197-214. Review.

PMID:
25549406
24.

Hyperferritinaemia in dengue virus infected patients is associated with immune activation and coagulation disturbances.

van de Weg CA, Huits RM, Pannuti CS, Brouns RM, van den Berg RW, van den Ham HJ, Martina BE, Osterhaus AD, Netea MG, Meijers JC, van Gorp EC, Kallas EG.

PLoS Negl Trop Dis. 2014 Oct 9;8(10):e3214. doi: 10.1371/journal.pntd.0003214. eCollection 2014 Oct.

25.

Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challenge.

van den Doel P, Volz A, Roose JM, Sewbalaksing VD, Pijlman GP, van Middelkoop I, Duiverman V, van de Wetering E, Sutter G, Osterhaus AD, Martina BE.

PLoS Negl Trop Dis. 2014 Sep 4;8(9):e3101. doi: 10.1371/journal.pntd.0003101. eCollection 2014 Sep.

26.

The hanta hunting study: underdiagnosis of Puumala hantavirus infections in symptomatic non-travelling leptospirosis-suspected patients in the Netherlands, in 2010 and April to November 2011.

Goeijenbier M, Hartskeerl RA, Reimerink J, Verner-Carlsson J, Wagenaar JF, Goris MG, Martina BE, Lundkvist Å, Koopmans M, Osterhaus AD, van Gorp EC, Reusken CB.

Euro Surveill. 2014 Aug 14;19(32). pii: 20878.

27.

A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice.

Koraka P, Bosch BJ, Cox M, Chubet R, Amerongen Gv, Lövgren-Bengtsson K, Martina BE, Roose J, Rottier PJ, Osterhaus AD.

Vaccine. 2014 Aug 6;32(36):4644-50. doi: 10.1016/j.vaccine.2014.06.058. Epub 2014 Jun 21.

PMID:
24962755
28.

Serum angiopoietin-2 and soluble VEGF receptor 2 are surrogate markers for plasma leakage in patients with acute dengue virus infection.

van de Weg CA, Pannuti CS, van den Ham HJ, de Araújo ES, Boas LS, Felix AC, Carvalho KI, Levi JE, Romano CM, Centrone CC, Rodrigues CL, Luna E, van Gorp EC, Osterhaus AD, Kallas EG, Martina BE.

J Clin Virol. 2014 Aug;60(4):328-35. doi: 10.1016/j.jcv.2014.05.001. Epub 2014 May 13.

29.

Activation of coagulation and tissue fibrin deposition in experimental influenza in ferrets.

Goeijenbier M, van Gorp EC, Van den Brand JM, Stittelaar K, Bakhtiari K, Roelofs JJ, van Amerongen G, Kuiken T, Martina BE, Meijers JC, Osterhaus AD.

BMC Microbiol. 2014 May 30;14:134. doi: 10.1186/1471-2180-14-134.

30.

Susceptibility of European jackdaws (Corvus monedula) to experimental infection with lineage 1 and 2 West Nile viruses.

Lim SM, Brault AC, van Amerongen G, Sewbalaksing VD, Osterhaus AD, Martina BE, Koraka P.

J Gen Virol. 2014 Jun;95(Pt 6):1320-9. doi: 10.1099/vir.0.063651-0. Epub 2014 Mar 26.

31.

Human arthropod-borne viral infections.

Manzin A, Martina BE, Gould EA, Bagnarelli P, Sambri V.

Biomed Res Int. 2013;2013:608510. doi: 10.1155/2013/608510. Epub 2013 Dec 31. No abstract available.

32.

Chikungunya virus-like particles are more immunogenic in a lethal AG129 mouse model compared to glycoprotein E1 or E2 subunits.

Metz SW, Martina BE, van den Doel P, Geertsema C, Osterhaus AD, Vlak JM, Pijlman GP.

Vaccine. 2013 Dec 9;31(51):6092-6. doi: 10.1016/j.vaccine.2013.09.045. Epub 2013 Oct 5.

PMID:
24099875
33.

Characterization of the mouse neuroinvasiveness of selected European strains of West Nile virus.

Lim SM, Koraka P, van Boheemen S, Roose JM, Jaarsma D, van de Vijver DA, Osterhaus AD, Martina BE.

PLoS One. 2013 Sep 18;8(9):e74575. doi: 10.1371/journal.pone.0074575. eCollection 2013.

34.

Development of a strand-specific real-time qRT-PCR for the accurate detection and quantitation of West Nile virus RNA.

Lim SM, Koraka P, Osterhaus AD, Martina BE.

J Virol Methods. 2013 Dec;194(1-2):146-53. doi: 10.1016/j.jviromet.2013.07.050. Epub 2013 Aug 18.

PMID:
23965252
35.

Characterization of synthetic Chikungunya viruses based on the consensus sequence of recent E1-226V isolates.

Scholte FE, Tas A, Martina BE, Cordioli P, Narayanan K, Makino S, Snijder EJ, van Hemert MJ.

PLoS One. 2013 Aug 1;8(8):e71047. doi: 10.1371/journal.pone.0071047. Print 2013.

36.

Microbial translocation is associated with extensive immune activation in dengue virus infected patients with severe disease.

van de Weg CA, Pannuti CS, de Araújo ES, van den Ham HJ, Andeweg AC, Boas LS, Felix AC, Carvalho KI, de Matos AM, Levi JE, Romano CM, Centrone CC, de Lima Rodrigues CL, Luna E, van Gorp EC, Osterhaus AD, Martina BE, Kallas EG.

PLoS Negl Trop Dis. 2013 May 23;7(5):e2236. doi: 10.1371/journal.pntd.0002236. Print 2013.

37.

In vitro and in vivo isolation and characterization of Duvenhage virus.

Koraka P, Martina BE, Roose JM, van Thiel PP, van Amerongen G, Kuiken T, Osterhaus AD.

PLoS Pathog. 2012;8(5):e1002682. doi: 10.1371/journal.ppat.1002682. Epub 2012 May 24.

38.

Evaluation of the 2009 WHO dengue case classification in an Indonesian pediatric cohort.

van de Weg CA, van Gorp EC, Supriatna M, Soemantri A, Osterhaus AD, Martina BE.

Am J Trop Med Hyg. 2012 Jan;86(1):166-70. doi: 10.4269/ajtmh.2012.11-0491.

39.

Lipopolysaccharide levels are elevated in dengue virus infected patients and correlate with disease severity.

van de Weg CA, Koraka P, van Gorp EC, Mairuhu AT, Supriatna M, Soemantri A, van de Vijver DA, Osterhaus AD, Martina BE.

J Clin Virol. 2012 Jan;53(1):38-42. doi: 10.1016/j.jcv.2011.09.028. Epub 2011 Oct 19.

40.

West Nile virus: immunity and pathogenesis.

Lim SM, Koraka P, Osterhaus AD, Martina BE.

Viruses. 2011 Jun;3(6):811-28. doi: 10.3390/v3060811. Epub 2011 Jun 15. Review.

41.

[West Nile virus expanding in Europe].

Reusken CB, van Maanen CK, Martina BE, Sonder GJ, van Gorp EC, Koopmans MP.

Ned Tijdschr Geneeskd. 2011;155(39):A3715. Review. Dutch.

PMID:
21961690
42.

An unusual cause of a usual presentation. Hantavirus infection.

Goeijenbier M, Nur E, Goris M, Wagenaar JF, Grünberg K, Nurmohamed SA, Martina BE, Osterhaus AD, van Gorp EC.

Neth J Med. 2011 Jun;69(6):285-9. No abstract available.

43.

Enteric coronavirus in ferrets, The Netherlands.

Provacia LB, Smits SL, Martina BE, Raj VS, Doel PV, Amerongen GV, Moorman-Roest H, Osterhaus AD, Haagmans BL.

Emerg Infect Dis. 2011 Aug;17(8):1570-1. doi: 10.3201/eid1708.110115. No abstract available.

44.

Functional processing and secretion of Chikungunya virus E1 and E2 glycoproteins in insect cells.

Metz SW, Geertsema C, Martina BE, Andrade P, Heldens JG, van Oers MM, Goldbach RW, Vlak JM, Pijlman GP.

Virol J. 2011 Jul 15;8:353. doi: 10.1186/1743-422X-8-353.

45.

A recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virus.

Martina BE, van den Doel P, Koraka P, van Amerongen G, Spohn G, Haagmans BL, Provacia LB, Osterhaus AD, Rimmelzwaan GF.

PLoS One. 2011 Apr 26;6(4):e18995. doi: 10.1371/journal.pone.0018995.

46.

A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice.

Spohn G, Jennings GT, Martina BE, Keller I, Beck M, Pumpens P, Osterhaus AD, Bachmann MF.

Virol J. 2010 Jul 6;7:146. doi: 10.1186/1743-422X-7-146.

47.

Bioinformatics in new generation flavivirus vaccines.

Koraka P, Martina BE, Osterhaus AD.

J Biomed Biotechnol. 2010;2010:864029. doi: 10.1155/2010/864029. Epub 2010 May 10.

48.

Plasma levels of inter-alpha inhibitor proteins in children with acute Dengue virus infection.

Koraka P, Lim YP, Shin MD, Setiati TE, Mairuhu AT, van Gorp EC, Soemantri A, Osterhaus AD, Martina BE.

PLoS One. 2010 Apr 6;5(4):e9967. doi: 10.1371/journal.pone.0009967.

49.

West Nile Virus: is a vaccine needed?

Martina BE, Koraka P, Osterhaus AD.

Curr Opin Investig Drugs. 2010 Feb;11(2):139-46. Review.

PMID:
20112163
50.

"Filoviruses": a real pandemic threat?

Martina BE, Osterhaus AD.

EMBO Mol Med. 2009 Apr;1(1):10-8. doi: 10.1002/emmm.200900005.

Supplemental Content

Loading ...
Support Center